Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart

Raphael M. Singh, Tahreem Waqar, Frank C. Howarth, Ernest Adeghate, Keshore Bidasee, Jaipaul Singh

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in ryanodine receptor, reduced activity of the sarcoplasmic reticulum calcium pump (SERCA) and, along with reduced activity of the sodium-calcium exchanger (NCX) and alterations in myofilament, collectively cause a calcium imbalance within the diabetic cardiomyocytes. This in turn is characterized by cytosolic calcium overloading or elevated diastolic calcium leading to heart failure. Numerous studies have been performed to identify the cellular, subcellular, and molecular derangements in diabetes-induced cardiomyopathy (DCM), but the precise mechanism(s) is still unknown. This review focuses on the mechanism behind DCM, the onset of contractile dysfunction, and the associated changes with special emphasis on hyperglycemia, mitochondrial dysfunction in the diabetic heart. Further, management strategies, including treatment and emerging therapeutic modalities, are discussed.

Original languageEnglish (US)
Pages (from-to)37-54
Number of pages18
JournalHeart Failure Reviews
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Hyperglycemia
Calcium
Cardiomyopathies
Sodium-Calcium Exchanger
Diabetic Cardiomyopathies
Ryanodine Receptor Calcium Release Channel
Myofibrils
Sarcoplasmic Reticulum
Cardiac Myocytes
Homeostasis
Heart Failure
Therapeutics

Keywords

  • Calcium transients [Ca]
  • Contractile dysfunction
  • Diabetic cardiomyopathy
  • Hyperglycemia
  • Sarcoplasmic reticulum calcium ATPase (SERCA)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart. / Singh, Raphael M.; Waqar, Tahreem; Howarth, Frank C.; Adeghate, Ernest; Bidasee, Keshore; Singh, Jaipaul.

In: Heart Failure Reviews, Vol. 23, No. 1, 01.01.2018, p. 37-54.

Research output: Contribution to journalReview article

Singh, Raphael M. ; Waqar, Tahreem ; Howarth, Frank C. ; Adeghate, Ernest ; Bidasee, Keshore ; Singh, Jaipaul. / Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart. In: Heart Failure Reviews. 2018 ; Vol. 23, No. 1. pp. 37-54.
@article{5ddaadcf486d4ca4babab3f72f141f33,
title = "Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart",
abstract = "The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in ryanodine receptor, reduced activity of the sarcoplasmic reticulum calcium pump (SERCA) and, along with reduced activity of the sodium-calcium exchanger (NCX) and alterations in myofilament, collectively cause a calcium imbalance within the diabetic cardiomyocytes. This in turn is characterized by cytosolic calcium overloading or elevated diastolic calcium leading to heart failure. Numerous studies have been performed to identify the cellular, subcellular, and molecular derangements in diabetes-induced cardiomyopathy (DCM), but the precise mechanism(s) is still unknown. This review focuses on the mechanism behind DCM, the onset of contractile dysfunction, and the associated changes with special emphasis on hyperglycemia, mitochondrial dysfunction in the diabetic heart. Further, management strategies, including treatment and emerging therapeutic modalities, are discussed.",
keywords = "Calcium transients [Ca], Contractile dysfunction, Diabetic cardiomyopathy, Hyperglycemia, Sarcoplasmic reticulum calcium ATPase (SERCA)",
author = "Singh, {Raphael M.} and Tahreem Waqar and Howarth, {Frank C.} and Ernest Adeghate and Keshore Bidasee and Jaipaul Singh",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s10741-017-9663-y",
language = "English (US)",
volume = "23",
pages = "37--54",
journal = "Heart Failure Reviews",
issn = "1382-4147",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart

AU - Singh, Raphael M.

AU - Waqar, Tahreem

AU - Howarth, Frank C.

AU - Adeghate, Ernest

AU - Bidasee, Keshore

AU - Singh, Jaipaul

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in ryanodine receptor, reduced activity of the sarcoplasmic reticulum calcium pump (SERCA) and, along with reduced activity of the sodium-calcium exchanger (NCX) and alterations in myofilament, collectively cause a calcium imbalance within the diabetic cardiomyocytes. This in turn is characterized by cytosolic calcium overloading or elevated diastolic calcium leading to heart failure. Numerous studies have been performed to identify the cellular, subcellular, and molecular derangements in diabetes-induced cardiomyopathy (DCM), but the precise mechanism(s) is still unknown. This review focuses on the mechanism behind DCM, the onset of contractile dysfunction, and the associated changes with special emphasis on hyperglycemia, mitochondrial dysfunction in the diabetic heart. Further, management strategies, including treatment and emerging therapeutic modalities, are discussed.

AB - The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in ryanodine receptor, reduced activity of the sarcoplasmic reticulum calcium pump (SERCA) and, along with reduced activity of the sodium-calcium exchanger (NCX) and alterations in myofilament, collectively cause a calcium imbalance within the diabetic cardiomyocytes. This in turn is characterized by cytosolic calcium overloading or elevated diastolic calcium leading to heart failure. Numerous studies have been performed to identify the cellular, subcellular, and molecular derangements in diabetes-induced cardiomyopathy (DCM), but the precise mechanism(s) is still unknown. This review focuses on the mechanism behind DCM, the onset of contractile dysfunction, and the associated changes with special emphasis on hyperglycemia, mitochondrial dysfunction in the diabetic heart. Further, management strategies, including treatment and emerging therapeutic modalities, are discussed.

KW - Calcium transients [Ca]

KW - Contractile dysfunction

KW - Diabetic cardiomyopathy

KW - Hyperglycemia

KW - Sarcoplasmic reticulum calcium ATPase (SERCA)

UR - http://www.scopus.com/inward/record.url?scp=85035768762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035768762&partnerID=8YFLogxK

U2 - 10.1007/s10741-017-9663-y

DO - 10.1007/s10741-017-9663-y

M3 - Review article

C2 - 29192360

AN - SCOPUS:85035768762

VL - 23

SP - 37

EP - 54

JO - Heart Failure Reviews

JF - Heart Failure Reviews

SN - 1382-4147

IS - 1

ER -